Efalizumab for the treatment of refractory hidradenitis suppurativa
Gespeichert in:
| Veröffentlicht in: | Journal of the American Academy of Dermatology 2007-12, Vol.57 (6), p.1090-1091 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1091 |
|---|---|
| container_issue | 6 |
| container_start_page | 1090 |
| container_title | Journal of the American Academy of Dermatology |
| container_volume | 57 |
| creator | Strober, Bruce E., MD, PhD Kim, Carolyn, MD Siu, Kimberly, MD |
| description | |
| doi_str_mv | 10.1016/j.jaad.2007.07.032 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68526872</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0190962207011802</els_id><sourcerecordid>68526872</sourcerecordid><originalsourceid>FETCH-LOGICAL-c409t-1a7531e6c0556c3ed7b9cb70f312050086b5d33335fa061cfc41ad1e2389054d3</originalsourceid><addsrcrecordid>eNp9kU9rGzEQxUVISVwnX6CHsqfc1h1JXmkXSiEYtwkYemh7FlppFmu7f1xJa3A-fVfYEMghYkCX9x7zfkPIJworClR8aVet1nbFAOQqDWdXZEGhkrmQpbwmC6AV5JVg7JZ8DKEFgGrN5Q25pSUwWhZsQTbbRnfuZep1nTWjz-Ies-hRxx6HmI1N5rHx2sTRn7K9s15bHFx0IQvT4TB5Hd1R35EPc0jA-8u_JH--b39vnvLdzx_Pm8ddbtZQxZxqWXCKwkBRCMPRyroytYSGUwYFQCnqwvL5FY0GQU1j1lRbioyXFRRry5fk4Zx78OO_CUNUvQsGu04POE5BibmRKCWbhewsNH4MYW6gDt712p8UBZXQqVYldCqhU2l4Mn2-pE91j_bVcmE1C76eBTh3PDr0KhiHg0HrPJqo7Ojez__2xm46Nziju794wtCOkx9meoqqwBSoX-l46XYggaYd-H9hvpQB</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68526872</pqid></control><display><type>article</type><title>Efalizumab for the treatment of refractory hidradenitis suppurativa</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Strober, Bruce E., MD, PhD ; Kim, Carolyn, MD ; Siu, Kimberly, MD</creator><creatorcontrib>Strober, Bruce E., MD, PhD ; Kim, Carolyn, MD ; Siu, Kimberly, MD</creatorcontrib><identifier>ISSN: 0190-9622</identifier><identifier>EISSN: 1097-6787</identifier><identifier>DOI: 10.1016/j.jaad.2007.07.032</identifier><identifier>PMID: 18021852</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Adolescent ; Adult ; Antibodies, Monoclonal - adverse effects ; Antibodies, Monoclonal - therapeutic use ; Dermatology ; Female ; Hidradenitis Suppurativa - drug therapy ; Humans ; Middle Aged</subject><ispartof>Journal of the American Academy of Dermatology, 2007-12, Vol.57 (6), p.1090-1091</ispartof><rights>American Academy of Dermatology, Inc.</rights><rights>2007 American Academy of Dermatology, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c409t-1a7531e6c0556c3ed7b9cb70f312050086b5d33335fa061cfc41ad1e2389054d3</citedby><cites>FETCH-LOGICAL-c409t-1a7531e6c0556c3ed7b9cb70f312050086b5d33335fa061cfc41ad1e2389054d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jaad.2007.07.032$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18021852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Strober, Bruce E., MD, PhD</creatorcontrib><creatorcontrib>Kim, Carolyn, MD</creatorcontrib><creatorcontrib>Siu, Kimberly, MD</creatorcontrib><title>Efalizumab for the treatment of refractory hidradenitis suppurativa</title><title>Journal of the American Academy of Dermatology</title><addtitle>J Am Acad Dermatol</addtitle><subject>Adolescent</subject><subject>Adult</subject><subject>Antibodies, Monoclonal - adverse effects</subject><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Dermatology</subject><subject>Female</subject><subject>Hidradenitis Suppurativa - drug therapy</subject><subject>Humans</subject><subject>Middle Aged</subject><issn>0190-9622</issn><issn>1097-6787</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kU9rGzEQxUVISVwnX6CHsqfc1h1JXmkXSiEYtwkYemh7FlppFmu7f1xJa3A-fVfYEMghYkCX9x7zfkPIJworClR8aVet1nbFAOQqDWdXZEGhkrmQpbwmC6AV5JVg7JZ8DKEFgGrN5Q25pSUwWhZsQTbbRnfuZep1nTWjz-Ies-hRxx6HmI1N5rHx2sTRn7K9s15bHFx0IQvT4TB5Hd1R35EPc0jA-8u_JH--b39vnvLdzx_Pm8ddbtZQxZxqWXCKwkBRCMPRyroytYSGUwYFQCnqwvL5FY0GQU1j1lRbioyXFRRry5fk4Zx78OO_CUNUvQsGu04POE5BibmRKCWbhewsNH4MYW6gDt712p8UBZXQqVYldCqhU2l4Mn2-pE91j_bVcmE1C76eBTh3PDr0KhiHg0HrPJqo7Ojez__2xm46Nziju794wtCOkx9meoqqwBSoX-l46XYggaYd-H9hvpQB</recordid><startdate>20071201</startdate><enddate>20071201</enddate><creator>Strober, Bruce E., MD, PhD</creator><creator>Kim, Carolyn, MD</creator><creator>Siu, Kimberly, MD</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20071201</creationdate><title>Efalizumab for the treatment of refractory hidradenitis suppurativa</title><author>Strober, Bruce E., MD, PhD ; Kim, Carolyn, MD ; Siu, Kimberly, MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c409t-1a7531e6c0556c3ed7b9cb70f312050086b5d33335fa061cfc41ad1e2389054d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antibodies, Monoclonal - adverse effects</topic><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Dermatology</topic><topic>Female</topic><topic>Hidradenitis Suppurativa - drug therapy</topic><topic>Humans</topic><topic>Middle Aged</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Strober, Bruce E., MD, PhD</creatorcontrib><creatorcontrib>Kim, Carolyn, MD</creatorcontrib><creatorcontrib>Siu, Kimberly, MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American Academy of Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Strober, Bruce E., MD, PhD</au><au>Kim, Carolyn, MD</au><au>Siu, Kimberly, MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Efalizumab for the treatment of refractory hidradenitis suppurativa</atitle><jtitle>Journal of the American Academy of Dermatology</jtitle><addtitle>J Am Acad Dermatol</addtitle><date>2007-12-01</date><risdate>2007</risdate><volume>57</volume><issue>6</issue><spage>1090</spage><epage>1091</epage><pages>1090-1091</pages><issn>0190-9622</issn><eissn>1097-6787</eissn><cop>United States</cop><pub>Mosby, Inc</pub><pmid>18021852</pmid><doi>10.1016/j.jaad.2007.07.032</doi><tpages>2</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0190-9622 |
| ispartof | Journal of the American Academy of Dermatology, 2007-12, Vol.57 (6), p.1090-1091 |
| issn | 0190-9622 1097-6787 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68526872 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Adolescent Adult Antibodies, Monoclonal - adverse effects Antibodies, Monoclonal - therapeutic use Dermatology Female Hidradenitis Suppurativa - drug therapy Humans Middle Aged |
| title | Efalizumab for the treatment of refractory hidradenitis suppurativa |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T12%3A19%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Efalizumab%20for%20the%20treatment%20of%20refractory%20hidradenitis%20suppurativa&rft.jtitle=Journal%20of%20the%20American%20Academy%20of%20Dermatology&rft.au=Strober,%20Bruce%20E.,%20MD,%20PhD&rft.date=2007-12-01&rft.volume=57&rft.issue=6&rft.spage=1090&rft.epage=1091&rft.pages=1090-1091&rft.issn=0190-9622&rft.eissn=1097-6787&rft_id=info:doi/10.1016/j.jaad.2007.07.032&rft_dat=%3Cproquest_cross%3E68526872%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68526872&rft_id=info:pmid/18021852&rft_els_id=S0190962207011802&rfr_iscdi=true |